Approval · Notice of Compliance 604 · 2002
CONRAY 325: Notice of Compliance 604
Issued July 2, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 604
- Date
- July 2, 2002
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Intravascular X-ray contrast medium
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONRAY 325 | 00405302 | Cancelled Post Market |
| CONRAY 400 | 00131547 | Cancelled Post Market |
Medicinal ingredients
- IOTHALAMATE SODIUM 54.3 PER
- IOTHALAMATE SODIUM 66.8 PER